Press "esc" to clear
Go to Advanced Search

Showing results

110 of 582

Article ID: 689313

Wall Street Journal Reporter John Carreyrou to Speak About His Work Investigating Startups in the Medical Testing Space at 70th AACC Annual Scientific Meeting

American Association for Clinical Chemistry (AACC)

AACC is pleased to announce that Wall Street Journal investigative reporter John Carreyrou will speak about his investigations into the laboratory medicine industry at the 70th AACC Annual Scientific Meeting & Clinical Lab Expo.

Released:
9-Feb-2018 3:45 PM EST
EXPERT AVAILABLE
Comment

Article ID: 688754

Breaking Research That Could Improve Treatment of Pregnancy Complications Published in AACC’s The Journal of Applied Laboratory Medicine

American Association for Clinical Chemistry (AACC)

A study in AACC’s The Journal of Applied Laboratory Medicine has for the first time established female-specific reference ranges for several biological variables that play key roles in thrombosis—or blood clotting—during pregnancy. This research could help lower the high U.S. maternal death rate by enabling more precise identification of pregnant women at risk for thrombosis-related complications such as preeclampsia.

Released:
31-Jan-2018 2:25 PM EST
EXPERT AVAILABLE
Comment

Article ID: 687967

AACC Releases Practice Guidelines for Using Laboratory Drug Tests to Combat Opioid Addiction, Overdoses

American Association for Clinical Chemistry (AACC)

WASHINGTON – AACC has issued a new guideline detailing how healthcare providers can use laboratory tests to manage treatment of pain and prevent prescription drug overdoses. Especially relevant in light of the worsening opioid epidemic, the guideline emphasizes increased collaboration between clinicians and laboratory experts as well as the use of more precise drug tests as key to identifying pain patients who are abusing their opioid prescriptions.

Released:
16-Jan-2018 11:05 AM EST
EXPERT AVAILABLE
Comment

Article ID: 687306

New Drug Testing Approach a Game-Changer for Benzodiazepine Abuse

American Association for Clinical Chemistry (AACC)

A first-of-its-kind study published in the Pain Management issue of AACC’s The Journal of Applied Laboratory Medicine shows that a new drug testing approach dramatically improves detection of illicit benzodiazepine use. This could help to curb abuse of these drugs, which are second only to opioids as a cause of prescription drug overdose deaths in the U.S.

Released:
2-Jan-2018 12:30 PM EST
EXPERT AVAILABLE
Comment

Channels:

All Journal News, Chemistry, Drugs and Drug Abuse, Pharmaceuticals, Local - DC, Local - DC Metro

Article ID: 687302

The Harmful Effects of Processed Carbs Supported by a New Study Published in AACC’s Journal Clinical Chemistry

American Association for Clinical Chemistry (AACC)

Innovative research published in the Obesity issue of AACC’s journal, Clinical Chemistry, demonstrates that people are at greater risk for obesity if they produce higher than normal levels of insulin after eating processed carbohydrates. These findings support the still controversial theory that refined carbs are driving the obesity epidemic.

Released:
2-Jan-2018 12:30 PM EST
EXPERT AVAILABLE
Comment

Article ID: 687305

Drug Tests That Could Halt Runaway Increase in Opioid Overdoses Highlighted in January Issue of AACC’s The Journal of Applied Laboratory Medicine

American Association for Clinical Chemistry (AACC)

A special issue of AACC’s The Journal of Applied Laboratory Medicine, “Laboratory Support of Pain Management,” features groundbreaking new drug tests that could reverse the staggering climb of prescription drug overdoses in the U.S.

Released:
2-Jan-2018 12:30 PM EST
EXPERT AVAILABLE
Comment

Channels:

All Journal News, Drugs and Drug Abuse, Pharmaceuticals, Local - DC, Local - DC Metro

Article ID: 687301

Research That Is Unraveling the Puzzle of Obesity Showcased in January Issue of AACC’s Journal Clinical Chemistry

American Association for Clinical Chemistry (AACC)

Laboratory medicine experts are using genomics, metabolomics, and other cutting-edge clinical testing methods to advance the understanding of obesity. A special issue of AACC’s journal Clinical Chemistry, “Obesity: Innovative Approaches to Overcome Obstacles,” highlights the latest innovations in the field that could lead to more effective public health policies to curb this epidemic.

Released:
2-Jan-2018 12:30 PM EST
EXPERT AVAILABLE
Comment

Channels:

Chemistry, Nursing, Obesity, Local - DC, Local - DC Metro, All Journal News

Article ID: 687188

Lab Tests Online Redesigns Website to Improve Patient Access to Crucial Information About Clinical Tests

American Association for Clinical Chemistry (AACC)

Lab Tests Online, AACC’s award-winning public resource on laboratory testing, is pleased to announce that it has launched a dynamic redesign of labtestsonline.org to better help patients, caregivers, and medical professionals understand the many lab tests that are an integral part of healthcare.

Released:
21-Dec-2017 10:10 AM EST
EXPERT AVAILABLE
Comment

Channels:

Healthcare, Patient Safety, Public Health, Local - DC, Local - DC Metro

Article ID: 684500

Understanding the Complexities of Non-Invasive Prenatal Screening for Pregnant Women

American Association for Clinical Chemistry (AACC)

As the use of non-invasive prenatal screening (NIPS) grows, there has been concern within the medical community that a poor understanding of this technique among clinicians and patients could negatively impact pregnancies. A review published today in AACC’s The Journal of Applied Laboratory Medicine gives an expert overview of NIPS’s many nuances, to arm healthcare providers with the information they need to ensure patients benefit from this revolutionary but complex technology.

Released:
2-Nov-2017 1:20 PM EDT
EXPERT AVAILABLE
Comment

Channels:

All Journal News, Technology, Women's Health, Local - DC, Local - DC Metro

Article ID: 683603

AACC Calls on CMS to Protect Patient Access to Essential Medical Tests

American Association for Clinical Chemistry (AACC)

Today, AACC sent a letter to the Centers for Medicare & Medicaid Services (CMS) in response to the agency’s proposed 2018 rates for clinical test reimbursement under the Protecting Access to Medicare Act (PAMA). In its statement, AACC expresses concern that the new payment rates could significantly limit patient access to crucial medical tests, and urges CMS to revise the rates in order to preserve high quality healthcare.

Released:
23-Oct-2017 11:00 AM EDT
EXPERT AVAILABLE
Comment

Channels:

Government/Law, Healthcare, Public Health, Local - DC, Local - DC Metro


Showing results

110 of 582





Chat now!